Editorial
Accepted on 25 Nov 2024
Editorial: Shaping the Future of Data Governance in African Health Research
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1525434
Type at least 3 characters
30 articles
Articles
Original Research
Published on 15 Oct 2024
Exploring global perspectives on the use of computer-based simulation in pharmacy education: a survey of students and educators
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1494569
- 537 views
Policy and Practice Reviews
Published on 27 Aug 2024
The anatomy of a data transfer agreement for health research
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1332700
- 655 views
Hypothesis and Theory
Published on 17 Jun 2024
Open optimism as an “embodied-health” ethic for the information era
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1331237
- 875 views
Original Research
Published on 10 May 2024
Do biobanks need pharmacists? Support of pharmacy students to biobanking of human biological material for pharmaceutical research and development
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1406866
- 1,163 views
Correction
Published on 14 Mar 2024
Corrigendum: Liability for harm caused by AI in healthcare: an overview of the core legal concepts
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1366004
- 891 views
- 1 citation
Policy and Practice Reviews
Published on 12 Mar 2024
Forcing a square into a circle: why South Africa’s draft revised material transfer agreement is not fit for purpose
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1333672
- 1,174 views
Review
Published on 01 Mar 2024
A pathway to strengthening open science: comments on the draft South African Ethics in Health Research Guidelines
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1304950
- 1,599 views
Original Research
Published on 20 Feb 2024
Patients’ knowledge, preferences, and perspectives about data protection and data control: an exploratory survey
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1280173
- 5,065 views
- 1 citation
Review
Published on 14 Dec 2023
Liability for harm caused by AI in healthcare: an overview of the core legal concepts
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1297353
- 5,165 views
- 6 citations
Perspective
Published on 23 Nov 2023
Does data protection law in South Africa apply to pseudonymised data?
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1238749
- 1,814 views
- 2 citations
Perspective
Published on 28 Aug 2023
Analysis of ethics dumping and proposed solutions in the field of biomedical research in China
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1214590
- 2,719 views
- 3 citations
Systematic Review
Published on 24 Aug 2023
Mapping the regulatory landscape of AI in healthcare in Africa
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1214422
- 10,455 views
- 13 citations
Editorial
Published on 12 Jun 2023
Editorial: Opportunities and challenges in reusing public genomics data
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1226756
- 2,018 views
Review
Published on 07 Apr 2023
The evolving culture of medical cannabis in Canada for the management of chronic pain
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1153584
- 10,562 views
- 9 citations
Review
Published on 26 Oct 2022
Fabry disease: Mechanism and therapeutics strategies
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1025740
- 12,441 views
- 22 citations